Jane Street’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $437M | Buy |
|
|||||
|
2025
Q2 | $7.45M | Sell |
|
|||||
|
2025
Q1 | $26.6M | Sell |
|
|||||
|
2024
Q4 | $37.8M | Buy |
|
|||||
|
2024
Q3 | $37.5M | Sell |
|
|||||
|
2024
Q2 | $33.9M | Sell |
|
|||||
|
2024
Q1 | $24.5M | Buy |
|
|||||
|
2023
Q4 | $18.6M | Buy |
|
|||||
|
2023
Q3 | $9.75M | Buy |
|
|||||
|
2023
Q2 | $6.96M | Sell |
|
|||||
|
2023
Q1 | $14.6M | Sell |
|
|||||
|
2022
Q4 | $28.3M | Sell |
|
|||||
|
2022
Q3 | $54.6M | Buy |
|
|||||
|
2022
Q2 | $18.9M | Buy |
|
|||||
|
2022
Q1 | $11M | Sell |
|
|||||
|
2021
Q4 | $19.7M | Buy |
|
|||||
|
2021
Q3 | $2.94M | Sell |
|
|||||
|
2021
Q2 | $10.2M | Buy |
|
|||||
|
2021
Q1 | $2.51M | Buy |
|
|||||
|
2020
Q4 | $895K | Sell |
|
|||||
|
2020
Q3 | $2.09M | Sell |
|
|||||
|
2020
Q2 | $11.8M | Buy |
|
|||||
|
2020
Q1 | $728K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $965K | Buy |
|
|||||
|
2019
Q2 | $855K | Sell |
|
|||||
|
2019
Q1 | $2.42M | Buy |
|
|||||
|
2018
Q4 | $1.07M | Sell |
|
|||||
|
2018
Q3 | $5.38M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.1M | Buy |
|
|||||
|
2017
Q4 | $413K | Sell |
|
|||||
|
2017
Q3 | $1.02M | Sell |
|
|||||
|
2017
Q2 | $703K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $1.67M | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $885K | Buy |
|
|||||
|
2015
Q4 | $857K | Buy |
|
|||||
|
2015
Q3 | $502K | Sell |
|
|||||
|
2015
Q2 | $3.23M | Buy |
|
|||||
|
2015
Q1 | $838K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $291K | Sell |
|
|||||
|
2014
Q1 | $1.04M | Sell |
|
|||||
|
2013
Q4 | $3.35M | Buy |
|